[PS2-4] Efficacy and safety of trastuzumab deruxtecan in HER2-expressing uterine carcinosarcoma: STATICE TRIAL (NCCH1615)
Abstract password authentication.
The password can be found on page 27 of the program book.
Presidential Session
Thu. Feb 17, 2022 8:30 AM - 10:00 AM Room 8 (Sakura, 1F, Kyoto International Conference Center)
Chair:Hiroji Iwata(Aichi Cancer Center Hospital),Tom Wei-Wu Chen(Department of Oncology, National Taiwan University Hospital)
Discussant:Junji Tsurutani(Advanced Cancer Translational Research Institute, Showa University),Tsutomu Iwasa(Department of Medical Oncology, Kindai University Faculty of Medicine),Naoki Niikura(Department of Breast Oncology, Tokai University),Katsutoshi Oda(Division of Integrative Genomics, The University of Tokyo)
Abstract password authentication.
The password can be found on page 27 of the program book.